Explore UAB
UAB News Stay informed with the latest updates
Articles Tagged
Campus & Community Published more than a year ago

Vivek Lal, M.D., associate professor in the Department of Pediatrics at UAB Heersink School of Medicine and the founder of both ResBiotic Nutrition and Alveolus Bio, was given the 2023 Award for Excellence in Entrepreneurship.

Research & Innovation Published more than a year ago

The Blazer Bridge Fund is intended to identify and assist in the development of promising ideas, discoveries, innovations and/or technologies from UAB faculty and staff that have commercial potential. 

Health & Medicine Published more than a year ago

IN8bio has opened a new Birmingham facility, a 10,000-square-foot advanced research and development laboratory in the Martin Biscuit Building at Pepper Place.

Research & Innovation Published more than a year ago

The spinoff company, IN8bio Inc., uses proprietary drug-resistant immunotherapy licensed in part from UAB. Glioblastoma is the most aggressive type of cancer originating in the brain.

Campus & Community Published more than a year ago

The funding from Alabama Innovation Corporation will help UAB startups make a profound impact in the biotechnology industry.

Health & Medicine Published more than a year ago

The Zorro-Flow Inc. is the newest startup from the UAB Harbert Institute for Innovation and Entrepreneurship. The device is the first external catheter to collect urine effectively, safely and comfortably from critically ill female neonates and children.

Health & Medicine Published more than a year ago

All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.

Research & Innovation Published more than a year ago

This therapy, using sustained release of nitric oxide, may be a novel, efficient and safe way to prevent and treat multiple metabolic diseases.

Research & Innovation Published more than a year ago

The monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used in humans.

Campus & Community Published more than a year ago

Collective strength of the research enterprise leads to almost $849 million in research grants and awards for FY 2021.

Research & Innovation Published more than a year ago

The life sciences fund will focus on development of early-stage UAB technologies and startup companies.

Research & Innovation Published more than a year ago

UAB professors publish distinct conceptual framework for entrepreneurship in educational settings.

Page 2 of 2

Back to Top